Biotech · Private company
Eirion Therapeutics Inc.
Track this companyFree. Adds Eirion Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- AI-09Phase 2 · Glabellar Frown LinesClinicalTrials.gov · fetched Nov 12, 2026
- AI-09 Ready Use Injectable Botulinum ToxinPhase 2 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- botulinum toxin, Type APhase 2 · Lateral Canthal LinesClinicalTrials.gov · fetched Nov 12, 2026
- botulinum toxin, Type APhase 2 · Lateral Canthal Lines, LCLClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Lateral Canthal Lines, LCLClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Glabellar Frown LinesClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Lateral Canthal LinesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Study to Evaluate AI-09 In Participants With Glabellar LinesPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 3, 2025ClinicalTrials.gov NCT07321834 · fetched Nov 12, 2026
- AI-09 In Subjects With Glabellar Lines, GL-101PHASE1_PHASE2 · COMPLETED · started Oct 3, 2022ClinicalTrials.gov NCT05565950 · fetched Nov 12, 2026
- ET-01 in Subjects With Lateral Canthal Lines, LCL-210PHASE2 · COMPLETED · started Jul 19, 2021ClinicalTrials.gov NCT04985916 · fetched Nov 12, 2026
- ET-01 in Subjects With Lateral Canthal Lines, LCL-209PHASE2 · COMPLETED · started Feb 27, 2019ClinicalTrials.gov NCT03912805 · fetched Nov 12, 2026
- ET-01 in Subjects With Lateral Canthal Lines, LCL-208PHASE2 · COMPLETED · started Oct 16, 2018ClinicalTrials.gov NCT03839693 · fetched Nov 12, 2026
- ET-01 in Subjects With Lateral Canthal Lines, LCL-207PHASE2 · COMPLETED · started Aug 16, 2018ClinicalTrials.gov NCT03655691 · fetched Nov 12, 2026
- ET-01 in Subjects With Lateral Canthal LinesPHASE2 · COMPLETED · started Oct 25, 2017ClinicalTrials.gov NCT03326856 · fetched Nov 12, 2026